Maybe it started with a clinic ad that called a treatment “FDA-registered,” or a flyer that called a procedure “established.” Now you are trying to work out whether that word means the product is safe, proven, or just allowed to be offered.
These words sound official, and they can make a decision feel safer than it is. “Regulatory status” is a narrow term, and clinics and sellers do not always use it the same way.
The short answer: regulatory status is a government classification or action about a product, not proof that it works for your condition. This guide explains what the term means, how to check a clinic’s wording, what research says about supplement claims and side effects, and what to ask before you decide.
| Regulatory status | The standing a product or ingredient holds under a government regulator’s rules. It is not proof that the product works. |
| Who decides it | A regulator such as the FDA, or an international authority, depending on the product and the country. |
| Supplement adverse events | A 2023 narrative review reports 79,071 adverse events related to dietary supplements reported to the FDA’s CFSAN system from 2004 to 2021. |
| Newer creatine forms | A 2011 review found little to no evidence that newer forms are more effective or safer than creatine monohydrate. |
| Trial IDs | Check that a cited trial studies the same product, use and condition you are being offered. |
| Your first request | Ask the clinic in writing for the exact status word, the product name and the regulator record behind it. |
Where are you starting?
Step 1: Learn what “regulatory status” means
You are at the start, with a word you keep seeing. Here, regulatory status means the standing a product or ingredient holds under a government regulator’s rules. Search results for this phrase also cover companies, financial firms and other topics. This guide stays with clinic and product claims.
A 2022 review in Nutrients uses the term for how international authorities classify creatine sold as a dietary supplement. It reports that creatine monohydrate is recognized by international regulatory authorities as safe for use in dietary supplements.
What this means for you: a status word names a rule or a classification. It does not name a result. Ask which regulator, which product and which use the word covers.
Read next
Regenerative Medicine Terms Explained: the words clinics use, with a plain definition for each.
For a wider orientation to the claims, read Regenerative Medicine Claims: A Reader’s Guide. Once the word is clear, check which status the clinic is actually claiming.
Step 2: Ask which status word the clinic means
You may be looking at a flyer or website that says “FDA-registered,” “established,” “approved,” or “clinical trial.” Treat them as separate claims, not one reassuring stamp.
When a clinic says a product is “FDA-registered,” that is the clinic’s statement. Ask to see the exact wording and the record it refers to. For the Investigational New Drug term specifically, see Investigational New Drug (IND) Language Explained. The nutrition.gov page on dietary supplements says to learn how these products are regulated and what to discuss with your healthcare provider before you start one, at nutrition.gov’s safety and health claims page.
What this means for you: ask the clinic to write down the status word, the product name and the record behind it. A vague answer is information too.
Read next
FDA Approval, Clinical Trials, and Clinic Marketing: how these terms are used in clinic marketing.
The phrase “FDA registered” has its own guide: What “FDA Registered” Can Mean. Next, look at the research behind any ingredient claim.
Step 3: Check supplement claims against the research
Some products are sold as supplements rather than treatments. Their claims often rest on one ingredient, and on whether a newer form of that ingredient is better. The nutrition.gov page from HHS and NIH lists a Federal Trade Commission resource on evaluating health claims for products, including supplements.
| Claim you may see | What the studies say |
| A newer form said to have better bioavailability | A 2011 review of novel forms found little to no evidence that newer forms are more effective or safer than creatine monohydrate. |
| Creatine monohydrate as the standard form | A 2022 critical review says it remains the only form with substantial evidence for bioavailability, efficacy and safety. |
| A form-specific safety claim | The 2011 review says the safety, efficacy and regulatory status of other forms is less clear than for creatine monohydrate. |
To read any ingredient claim, start with the exact form, the dose and the people studied. Ingredient Evidence vs. Marketing Claims explains how to match a claim to its evidence. How to Read a Clinical Study explains the study terms you will meet.
What this means for you: if a seller says its form works better, ask for the study of that exact form. A study of a different form does not transfer.
Read next
Stem Cell Source in a Treatment Claim: which cells were studied, and whether that matches the product offered.
Once you know what was studied, check whether the study matches the offer. That is the step covered next.
Step 4: Match a cited trial to the product you are offered
Your job is to see whether a cited study is about the same product, the same use and the same condition.
Start with three checks: the product name, the dose or procedure, and the condition. Then look at the trial’s status.
What this means for you: write down the trial ID and ask the clinic which product, dose and condition it covers. Compare the answers with the offer you were given, and note any differences.
Read next
Stem Cell Treatment Claims: How to Check FDA Status: a step-by-step check of the FDA status and trial record.
Two related guides cover a cited exosome trial, at An Exosome Offer Cites a Trial, and a completed trial with missing results, at A Completed Regenerative Trial With Missing Results. Next, weigh the stories and headlines you may have seen.
Step 5: Weigh success stories and headlines, then look at your options
Headlines call for the same checks. Check which exact product was studied, whether people were studied, and whether the results are posted. The 2023 narrative review on supplement adverse events also argues that FDA oversight of these products has relied mostly on monitoring after sale.
Your options usually start with a clinician visit, where you can ask which choices fit your situation. This guide does not cover prescription options for any specific condition, so ask a clinician about those. The nutrition.gov page lists why you should tell your doctor about every supplement and medication you take, at nutrition.gov’s safety and health claims page.
What this means for you: treat a testimonial as one person’s account. Ask what the clinic’s own study measured, and whether it compared the treatment with anything else.
Read next
Regenerative Medicine Testimonials: what a personal story can and cannot show.
For a headline, see Exosome Research Headlines. If a clinic’s claim conflicts with posted results, read When Posted Trial Results Conflict With a Clinic’s Claim.
Step 6: Look at side effects and how to report them
Safety evidence for supplements includes adverse event reports. The 2023 narrative review, built on case studies, counts 79,071 adverse events related to dietary supplements reported to the FDA’s Center for Food Safety and Applied Nutrition from 2004 to 2021. It says kratom is among the herbal products linked to organ failure. This guide does not address kratom’s legal status.
A 2017 systematic review looked at 26 published supplement studies of the QT interval, a heart-rhythm measurement. Eight studies found a significant change in QT/QTc intervals. More than 30% showed some degree of ECG change.
What this means for you: if you notice a reaction, contact a clinician promptly. The nutrition.gov page links the FDA’s process for reporting health-related reactions to dietary supplements.
Read next
Reporting a Regenerative Medicine Side Effect: where and how to raise a concern about a product.
For regulatory questions on exosome products, see Exosome Products: Regulatory Questions and Safety Boundaries. For serious events in cell therapy, see Cell Therapy Safety Reports.
Step 7: Get the costs, consent and travel questions in writing
Before you pay, ask what the fee covers. Ask whether follow-up visits, extra injections or products are billed separately. Ask the clinic to explain what it expects you to gain and what the alternatives are.
If a clinic offers a trip abroad, ask the same questions you would ask locally. Also ask who will follow you up after you return home.
What this means for you: ask for every cost and every follow-up step in writing before you sign. A verbal price is not a written term.
Read next
Regenerative Treatment Costs: separating the fee, follow-up and any unproven benefit.
For the consent conversation, see Procedure Consent Questions. If travel is part of the plan, read Unproven Stem Cell Claims and Travel.
Your next step
- Write down the exact status word the clinic or seller uses, and the product name.
- Ask which regulator record, if any, supports that word, and ask for a copy.
- Ask for the trial ID and check whether it studies the same product, dose, use and condition.
- Ask for every cost, follow-up visit and refund term in writing.
- Take these questions to a clinician who knows your health history before you decide.
Every guide on this topic
Reading the status words
- Regenerative Medicine Terms Explained
- What “FDA Registered” Can Mean
- FDA Approval, Clinical Trials, and Clinic Marketing
- Investigational New Drug (IND) Language Explained
- Expanded Access vs. Clinical Trials
- An Investigational Procedure Sold as Established
- Clinical Trial Status Labels Explained
- What an Institutional Review Board Does
Checking claims and trial records
- Stem Cell Treatment Claims: How to Check FDA Status
- An Exosome Offer Cites a Trial
- A Completed Regenerative Trial With Missing Results
- When Posted Trial Results Conflict With a Clinic’s Claim
- Stem Cell Source in a Treatment Claim
- Platelet-Rich Plasma Study Claims
- Surrogate Outcomes and Patient Outcomes
- Regenerative Procedure Comparisons
- Leaving a Regenerative Clinical Trial
- Data Safety Monitoring (DSMB) Explained
Testimonials, headlines and claim basics
- Regenerative Medicine Testimonials
- Exosome Research Headlines
- Regenerative Medicine Claims: A Reader’s Guide
- Recovery Claims After a Procedure
Safety and reporting
- Reporting a Regenerative Medicine Side Effect
- Exosome Products: Regulatory Questions and Safety Boundaries
- Cell Therapy Safety Reports
- Adverse Event Reports and Safety Evidence
- Research Injury Costs: Questions Before Joining
- Recovery Planning After a Procedure
- Transdermal Magnesium Absorption and Safety
- Rest After a Cortisone Injection
Costs, consent and travel
- Regenerative Treatment Costs
- Procedure Consent Questions
- Questions Before a Regenerative Procedure Conversation
- Research Consent for a Clinical Study
- Unproven Stem Cell Claims and Travel
Disclosure: this guide is for education. It does not replace care from a qualified professional, and it does not recommend any product.
By Regenerative Evidence Guide Editorial Team